Friday morning was brutal for Autolus Therapeutics (AUTL) and its investors as shares plummeted over 35%. This was caused by the announcement executives at the company made yesterday after the market closed. In short, the company is diluting the shares and diminishing stock value. The company plans to initiate 75 million American depositary shares [...]